ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "cyclin-dependent kinase"
cyclin-dependent kinase
Publikace
Předměty
Osoby
Publikace
Studium
Exportovat aktuální pohled
publication
Cyklin-dependentní kinázy – cíl vhodný k ovlivnění metastatického karcinomu prsu
2021 |
1. lékařská fakulta
publication
Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinase inhibitor, bohemine
2002 |
Přírodovědecká fakulta
publication
LC-MS/MS method for determination of cyclin-dependent kinase inhibitors, BP-14 and BP-20, and its application in pharmacokinetic study in rat
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
2015 |
1. lékařská fakulta
publication
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
2015 |
Farmaceutická fakulta v Hradci Králové
publication
8-Azapurines as new inhibitors of cyclin-dependent kinases
2005 |
1. lékařská fakulta
publication
8-Azapurines as new inhibitors of cyclin-dependent kinases
2005 |
Fakulta tělesné výchovy a sportu
publication
Synthetic cyclin-dependent kinase inhibitors. New generation of potent anti-cancer drugs.
1999 |
Fakulta tělesné výchovy a sportu
publication
Molecular nature of cytokinin binding in ATP binding pocket of cyclin-dependent kinases.
1999 |
Fakulta tělesné výchovy a sportu
publication
3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models
2019 |
1. lékařská fakulta, Matematicko-fyzikální fakulta
publication
3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders
2022 |
1. lékařská fakulta, Ústřední knihovna
publication
Metabolism of cyclin-dependent kinase inhibitor bohemine at the cellular and subcellular levels
Publikace bez příslušnosti k fakultě
publication
Adjuvantní léčba karcinomu prsu inhibitory CDK4/6
2023 |
1. lékařská fakulta
publication
In vitro glycosidation potential towards olomoucine-type cyclin-dependent kinase inhibitors in rodent and primate microsomes
2003 |
1. lékařská fakulta
publication
In vitro glycosidation potential towards olomoucine-type cyclin-dependent kinase inhibitors in rodent and primate microsomes
2003 |
Fakulta tělesné výchovy a sportu
publication
Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinase inhibitor, bohemine
2002 |
1. lékařská fakulta, Matematicko-fyzikální fakulta
publication
Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors: Synthesis and cdc2 Inhibitory Activity of Olomoucine and Related Compounds.
1997 |
Fakulta tělesné výchovy a sportu
publication
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
2015 |
Farmaceutická fakulta v Hradci Králové
publication
Identification of novel candidate proteins for anti-cancer activity of olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.
2001 |
Přírodovědecká fakulta
publication
Identification of novel candidate proteins for anti-cancer activity of olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.
2001 |
1. lékařská fakulta, Matematicko-fyzikální fakulta
publication
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk
2016 |
1. lékařská fakulta, Lékařská fakulta v Plzni
publication
Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture
2001 |
2. lékařská fakulta
publication
CKS1 Germ Line Exclusion Is Essential for the Transition from Meiosis to Early Embryonic Development
2019 |
Přírodovědecká fakulta
publication
Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters
2019 |
Farmaceutická fakulta v Hradci Králové
publication
Olomoucine II and purvalanol A inhibit ABCG2 transporter in vitro and in situ and synergistically potentiate cytostatic effect of mitoxantrone
2012 |
Farmaceutická fakulta v Hradci Králové
publication
DNA content in Acanthamoeba during two stress defense reactions: Encystation, pseudocyst formation and cell cycle
2021 |
1. lékařská fakulta
publication
Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
2016 |
1. lékařská fakulta, Ústřední knihovna
publication
Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein (ABCB1), breast cancer resistance protein (ABCG2) and multidrug resistance-associated proteins (ABCCs)
2016 |
Farmaceutická fakulta v Hradci Králové
publication
Zhodnocení studie MONARCH 2
2020 |
Lékařská fakulta v Hradci Králové
publication
In vivo metabolism of 2, 6, 9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route
2001 |
1. lékařská fakulta